Significant Increase in Plasma Thyroid-Stimulating Hormone During Low-Frequency Repetitive Transcranial Magnetic Stimulation
Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Repetitive transcranial magnetic stimulation (rTMS) is efficacious in treatment-resistant depression when applied with high-frequency stimulation (HF-rTMS: 5 Hz to 25 Hz) over the left dorsolateral prefrontal cortex (PFC) and with low-frequency stimulation (LF-rTMS≤1 Hz) over the right dorsolateral PFC.1 rTMS is known to be painless and well-tolerated, and does not require, as a rule, either premedication or special biological monitoring.
However, rTMS seems to influence the hypothalamo-pituitary-thyroid axis. We report, here, the first case of thyroid-stimulating hormone (TSH) increase occurring during LF-rTMS for treatment of depression.
Case Report
A 60-year-old woman was hospitalized for a treatment-resistant depression lasting for 2 years. She was treated with T4, 100 μg/day, after complete thyroidectomy for a multinodular goiter 13 years ago. Her plasma TSH levels had been stable, between 1 and 2 mU/liter (normal range: 0.4–3.4) for a long time, as were her thyroid hormone levels. Antidepressants previously prescribed to the patient never affected her thyroid function. On admission, levels of TSH and free T4 were 1.560 mU/L and 13.3 pmol/liter (normal range: 9.8–18.8), respectively.
For her treatment-resistant depression, daily rTMS sessions from Monday through Friday were delivered over 6 weeks in addition to her latest antidepressant (venlafaxine). The patient received LF-rTMS (1 Hz) to the right dorsolateral PFC (360 pulses per session, 120% motor threshold), and blood thyroid levels were obtained each Wednesday at 7 A.M.
Her serum TSH rapidly increased after beginning rTMS, up to 5.19 mU/L, and remained abnormally elevated during the whole rTMS period. When rTMS treatment was stopped 6 weeks later, plasma TSH returned to normal. In this patient treated with T4, after thyroidectomy, free T4 levels remained unchanged during the rTMS treatment period.
Discussion
So far, very little is known on the impact of rTMS on hypothalamo-pituitary-thyroid axis.2 A slight increase in plasma TSH level, remaining in the normal ranges, has been reported in healthy volunteers and in depressed patients with HF-rTMS (5 Hz to 20 Hz).1,3,4 In our present case, we report a significant increase in plasma TSH, above normal range, during LF-rTMS (1 Hz) treatment. Because our patient had a history of thyroidectomy, this rise in TSH did not induce any increase in plasma T4 level. In patients with a normal thyroid gland, we may expect an increase in plasma T4 secondary to the LF-rTMS-induced rise in plasma TSH. Such an increase in plasma T4 level has been recently suspected by Osuch et al.5 during treatment of anxiety disorders by LF-rTMS. Thus, rTMS can have significant effects on the pituitary-thyroid axis that may potentially induce hyperthyroidism. Further studies are needed to assess the effects of rTMS on thyroid function.
References
1.
Cohrs S, Tergau F, Korn J, et al.: Suprathreshold repetitive transcranial magnetic stimulation elevates thyroid-stimulating hormone in healthy male subjects. J Nerv Ment Dis 2001; 189:393–397
2.
Loo CK, McFarquhar TF, Mitchell PB: A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neurpsychopharmacol 2008; 11:131–147
3.
George MS, Wassermann EM, Williams WA, et al.: Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) over the prefrontal cortex. J Neuropsychiatry Clin Neurosci 1996; 8:172–180
4.
Szuba MP, O'Reardon JP, Rai AS, et al.: Acute mood and thyroid stimulating hormone effets of transcranial magnetic stimulation in major depression. Biol Psychiatry 2001; 50:22–27
5.
Osuch EA, Benson BE, Luckenbaugh DA, et al.: Repetitive TMS combined with exposure therapy for PTSD: a preliminary study. J Anxiety Disord 2009; 23:54–59
Information & Authors
Information
Published In
History
Published online: 1 January 2011
Published in print: Winter 2011
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
PDF/ePub
View PDF/ePubGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).